The main reason for this effect was that albumin nanoparticles utilized the GP60- and SPARC-mediated pathway for targeted DOX delivery, and the effect resulted in significant inhibition of tumor growth and lower exposure of major organs to DOX (Tan et al., 2021). The gene discussed is SPARC; the disease is neoplasm.